Common use of Record Tracking Clause in Contracts

Record Tracking. Status: Original 3/9/2021 10:35:21 AM Holder: EcoDev ▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Location: DocuSign ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Co-owner Security Level: Email, Account Authentication (None) Signature Adoption: Drawn on Device Using IP Address: 138.128.130.156 Sent: 3/9/2021 10:36:44 AM Viewed: 3/11/2021 7:16:49 PM Signed: 3/11/2021 7:19:36 PM Accepted: 3/11/2021 7:16:49 PM ID: d917a52d-07fa-473f-93c7-c2588924b405 Cam ▇▇▇▇▇▇ ▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Signature Adoption: Pre-selected Style Using IP Address: 72.16.81.2 Sent: 3/11/2021 7:19:38 PM Viewed: 3/12/2021 8:25:59 AM Signed: 3/12/2021 8:26:07 AM Accepted: 3/12/2021 8:25:59 AM ID: 3bb0d7d6-72a1-44cb-8d50-2a7ce8c383de ▇▇▇▇▇▇ ▇▇▇▇▇▇ III ▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Signature Adoption: Pre-selected Style Using IP Address: 72.16.81.2 Sent: 3/12/2021 8:26:08 AM Viewed: 3/12/2021 12:38:56 PM Signed: 3/12/2021 12:39:25 PM Accepted: 3/12/2021 12:38:56 PM ID: b4e24cf2-4452-41a9-bf30-5f1b3fe60d99 ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Records Information Manager City of Sugar Land Security Level: Email, Account Authentication (None) Not Offered via DocuSign Eco Dev E-Mail Address ▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Department Account City of Sugar Land Security Level: Email, Account Authentication (None) Not Offered via DocuSign ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Not Offered via DocuSign Sent: 3/12/2021 12:39:26 PM Sent: 3/12/2021 12:39:27 PM Sent: 3/12/2021 12:39:27 PM Envelope Sent Hashed/Encrypted 3/9/2021 10:36:44 AM Certified Delivered Security Checked 3/12/2021 12:38:56 PM Signing Complete Security Checked 3/12/2021 12:39:25 PM Completed Security Checked 3/12/2021 12:39:27 PM Electronic Record and Signature Disclosure created on: 3/20/2017 2:02:24 PM Parties agreed to: ▇▇▇▇▇ ▇▇▇▇▇▇▇, Cam ▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇ III From time to time, City of Sugar Land (we, us or Company) may be required by law to provide to you certain written notices or disclosures. Described below are the terms and conditions for providing to you such notices and disclosures electronically through your DocuSign, Inc. (DocuSign) Express user account. Please read the information below carefully and thoroughly, and if you can access this information electronically to your satisfaction and agree to these terms and conditions, please confirm your agreement by clicking the 'I agree' button at the bottom of this document. At any time, you may request from us a paper copy of any record provided or made available electronically to you by us. For such copies, as long as you are an authorized user of the DocuSign system you will have the ability to download and print any documents we send to you through your DocuSign user account for a limited period of time (usually 30 days) after such documents are first sent to you. After such time, if you wish for us to send you paper copies of any such documents from our office to you, you will be charged a $0.00 per-page fee. You may request delivery of such paper copies from us by following the procedure described below. If you decide to receive notices and disclosures from us electronically, you may at any time change your mind and tell us that thereafter you want to receive required notices and disclosures only in paper format. How you must inform us of your decision to receive future notices and disclosure in paper format and withdraw your consent to receive notices and disclosures electronically is described below. If you elect to receive required notices and disclosures only in paper format, it will slow the speed at which we can complete certain steps in transactions with you and delivering services to you because we will need first to send the required notices or disclosures to you in paper format, and then wait until we receive back from you your acknowledgment of your receipt of such paper notices or disclosures. To indicate to us that you are changing your mind, you must withdraw your consent using the DocuSign 'Withdraw Consent' form on the signing page of your DocuSign account. This will indicate to us that you have withdrawn your consent to receive required notices and disclosures electronically from us and you will no longer be able to use your DocuSign Express user account to receive required notices and consents electronically from us or to sign electronically documents from us. Unless you tell us otherwise in accordance with the procedures described herein, we will provide electronically to you through your DocuSign user account all required notices, disclosures, authorizations, acknowledgements, and other documents that are required to be provided or made available to you during the course of our relationship with you. To reduce the chance of you inadvertently not receiving any notice or disclosure, we prefer to provide all of the required notices and disclosures to you by the same method and to the same address that you have given us. Thus, you can receive all the disclosures and notices electronically or in paper format through the paper mail delivery system. If you do not agree with this process, please let us know as described below. Please also see the paragraph immediately above that describes the consequences of your electing not to receive delivery of the notices and disclosures electronically from us. You may contact us to let us know of your changes as to how we may contact you electronically, to request paper copies of certain information from us, and to withdraw your prior consent to receive notices and disclosures electronically as follows: To contact us by email send messages to: ▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ To let us know of a change in your e-mail address where we should send notices and disclosures electronically to you, you must send an email message to us at ▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ and in the body of such request you must state: your previous e-mail address, your new e-mail address. We do not require any other information from you to change your email address.. In addition, you must notify DocuSign, Inc to arrange for your new email address to be reflected in your DocuSign account by following the process for changing e-mail in DocuSign. To request delivery from us of paper copies of the notices and disclosures previously provided by us to you electronically, you must send us an e-mail to ▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ and in the body of such request you must state your e-mail address, full name, US Postal address, and telephone number. We will ▇▇▇▇ you for any fees at that time, if any. To inform us that you no longer want to receive future notices and disclosures in electronic format you may:

Record Tracking. Status: Original 3/9/2021 10:35:21 AM Holder: EcoDev ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Location: DocuSign 6/20/2014 11:51:06 AM ET ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Location: DocuSign ▇▇▇▇▇ ▇▇▇▇▇▇▇ Docusigned by: Sent: 6/24/2014 4:30:22 PM ET /s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇ Viewed: 6/24/2014 4:31:44 PM ET ▇▇▇▇.▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇ A54C2D48588B48F... Signed: 6/25/2014 2:49:32 PM ET Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Using IP Address: 204.14.70.178 Not Offered ID: ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Docusigned by Sent: 6/25/2014 2:49:33 PM ET /s/ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Viewed: 6/25/2014 3:02:54 PM ET ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Co-owner 96962A7213E74AD... Signed: 6/25/2014 3:03:49 PM ET SVP Development Security Level: Email, Account Authentication (None) Signature Adoption: Drawn on Device Using IP Address: 138.128.130.156 Sent199.68.16.14 Electronic Record and Signature Disclosure: 3/9/2021 10:36:44 AM Viewed: 3/11/2021 7:16:49 PM Signed: 3/11/2021 7:19:36 PM Accepted: 3/11/2021 7:16:49 PM Not Offered ID: d917a52d-07fa-473f-93c7-c2588924b405 Cam ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ COPIED Sent: 6/25/2014 3:03:49 PM ET ▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered ID: ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ COPIED Sent: 6/25/2014 3:03:50 PM ET ▇▇▇▇.▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered ID: ▇▇▇▇ ▇▇▇▇▇ COPIED Sent: 6/25/2014 3:03:51 PM ET ▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Electronic Record and Signature AdoptionDisclosure: Pre-selected Style Using IP Address: 72.16.81.2 Sent: 3/11/2021 7:19:38 PM Viewed: 3/12/2021 8:25:59 AM Signed: 3/12/2021 8:26:07 AM Accepted: 3/12/2021 8:25:59 AM Not Offered ID: 3bb0d7d6-72a1-44cb-8d50-2a7ce8c383de ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ III COPIED Sent: 6/25/2014 3:03:52 PM ET ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇.▇▇▇ MedImmune Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered ID: ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ COPIED Sent: 6/25/2014 3:03:52 PM ET ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Electronic Record and Signature AdoptionDisclosure: Pre-selected Style Using IP Address: 72.16.81.2 Sent: 3/12/2021 8:26:08 AM Viewed: 3/12/2021 12:38:56 PM Signed: 3/12/2021 12:39:25 PM Accepted: 3/12/2021 12:38:56 PM Not Offered ID: b4e24cf2-4452-41a9-bf30-5f1b3fe60d99 ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇@▇ COPIED Sent: 6/25/2014 3:03:53 PM ET ▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Records Information Manager City of Sugar Land Security Level: Email, Account Authentication (None) Not Offered via DocuSign Eco Dev E-Mail Address ▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Department Account City of Sugar Land Security Level: Email, Account Authentication (None) Not Offered via DocuSign ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered via DocuSign SentID: 3/12/2021 12:39:26 PM Sent: 3/12/2021 12:39:27 PM Sent: 3/12/2021 12:39:27 PM Envelope Sent Hashed/Encrypted 3/9/2021 10:36:44 AM 6/25/2014 3:03:53 PM ET Certified Delivered Security Checked 3/12/2021 12:38:56 6/25/2014 3:03:53 PM ET Signing Complete Security Checked 3/12/2021 12:39:25 6/25/2014 3:03:53 PM ET Completed Security Checked 3/12/2021 12:39:27 6/25/2014 3:03:53 PM Electronic Record and Signature Disclosure created on: 3/20/2017 2:02:24 PM Parties agreed to: ▇▇ET June 30, 2014 MedImmune, LLC ▇▇▇ ▇▇▇▇▇▇▇, Cam ▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇ III From time to time, City of Sugar Land (we, us or Company) may be required by law to provide to you certain written notices or disclosures. Described below are the terms and conditions for providing to you such notices and disclosures electronically through your DocuSign, Inc. (DocuSign) Express user account. Please read the information below carefully and thoroughly, and if you can access this information electronically to your satisfaction and agree to these terms and conditions, please confirm your agreement by clicking the 'I agree' button at the bottom of this document. At any time, you may request from us a paper copy of any record provided or made available electronically to you by us. For such copies, as long as you are an authorized user of the DocuSign system you will have the ability to download and print any documents we send to you through your DocuSign user account for a limited period of time (usually 30 days) after such documents are first sent to you. After such time, if you wish for us to send you paper copies of any such documents from our office to you, you will be charged a $0.00 per-page fee. You may request delivery of such paper copies from us by following the procedure described below. If you decide to receive notices and disclosures from us electronically, you may at any time change your mind and tell us that thereafter you want to receive required notices and disclosures only in paper format. How you must inform us of your decision to receive future notices and disclosure in paper format and withdraw your consent to receive notices and disclosures electronically is described below. If you elect to receive required notices and disclosures only in paper format, it will slow the speed at which we can complete certain steps in transactions with you and delivering services to you because we will need first to send the required notices or disclosures to you in paper format, and then wait until we receive back from you your acknowledgment of your receipt of such paper notices or disclosures. To indicate to us that you are changing your mind, you must withdraw your consent using the DocuSign 'Withdraw Consent' form on the signing page of your DocuSign account. This will indicate to us that you have withdrawn your consent to receive required notices and disclosures electronically from us and you will no longer be able to use your DocuSign Express user account to receive required notices and consents electronically from us or to sign electronically documents from us. Unless you tell us otherwise in accordance with the procedures described herein, we will provide electronically to you through your DocuSign user account all required notices, disclosures, authorizations, acknowledgements, and other documents that are required to be provided or made available to you during the course of our relationship with you. To reduce the chance of you inadvertently not receiving any notice or disclosure, we prefer to provide all of the required notices and disclosures to you by the same method and to the same address that you have given us. Thus, you can receive all the disclosures and notices electronically or in paper format through the paper mail delivery system. If you do not agree with this process, please let us know as described below. Please also see the paragraph immediately above that describes the consequences of your electing not to receive delivery of the notices and disclosures electronically from us. You may contact us to let us know of your changes as to how we may contact you electronically, to request paper copies of certain information from us, and to withdraw your prior consent to receive notices and disclosures electronically as follows: To contact us by email send messages to: ▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇, ▇▇ ▇▇▇▇▇ To let us know of a change in your eAttention: EVP, Research Facsimile: (▇▇▇) ▇▇▇-mail address where we should send notices and disclosures electronically to you▇▇▇▇ MedImmune, you must send an email message to us at LLC ▇▇▇ ▇▇▇▇▇▇▇@▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇.▇, ▇▇ and in the body of such request you must state: your previous e-mail address, your new e-mail address. We do not require any other information from you to change your email address.. In addition, you must notify DocuSign, Inc to arrange for your new email address to be reflected in your DocuSign account by following the process for changing e-mail in DocuSign. To request delivery from us of paper copies of the notices and disclosures previously provided by us to you electronically, you must send us an e-mail to ▇▇▇▇▇ Attention: Legal Department Facsimile: (▇▇▇@) ▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ and in the body of such request you must state your e-mail address, full name, US Postal address, and telephone number. We will ▇▇▇▇ you for any fees at Re: License and Option Agreement Ladies and Gentlemen: Reference is made to the License and Option Agreement, effective as of July 24, 2013, by and between MedImmune, LLC and Bulldog Pharmaceuticals, Inc., as amended by that timecertain letter agreement dated February 10, if any2014 and the Addendum to the License and Option Agreement, executed as of June 25, 2014 (collectively, the “Agreement”). To inform us that you no longer want Capitalized terms used but not defined in this letter have the meanings given to receive future notices them in the Agreement. The Parties desire (x) to clarify and disclosures in electronic format you maysupplement certain of their rights and obligations under the Agreement with respect to the Inventory and (y) to clarify their intention regarding the definition of MedImmune Manufacturing Information and Inventions. Accordingly, the Parties agree as follows:

Record Tracking. Status: Original 3/9/2021 10:35:21 AM Holder: EcoDev ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Location: DocuSign 6/20/2014 11:51:06 AM ET ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Location: DocuSign ▇▇▇▇▇ ▇▇▇▇▇▇▇ Docusigned by: Sent: 6/24/2014 4:30:22 PM ET /s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇ Viewed: 6/24/2014 4:31:44 PM ET ▇▇▇▇.▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇ A54C2D48588B48F... Signed: 6/25/2014 2:49:32 PM ET Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Using IP Address: 204.14.70.178 Not Offered ID: ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Docusigned by Sent: 6/25/2014 2:49:33 PM ET /s/ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Viewed: 6/25/2014 3:02:54 PM ET ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Co-owner 96962A7213E74AD... Signed: 6/25/2014 3:03:49 PM ET SVP Development Security Level: Email, Account Authentication (None) Signature Adoption: Drawn on Device Using IP Address: 138.128.130.156 Sent199.68.16.14 Electronic Record and Signature Disclosure: 3/9/2021 10:36:44 AM Viewed: 3/11/2021 7:16:49 PM Signed: 3/11/2021 7:19:36 PM Accepted: 3/11/2021 7:16:49 PM Not Offered ID: d917a52d-07fa-473f-93c7-c2588924b405 Cam ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ COPIED Sent: 6/25/2014 3:03:49 PM ET ▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered ID: ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ COPIED Sent: 6/25/2014 3:03:50 PM ET ▇▇▇▇.▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered ID: ▇▇▇▇ ▇▇▇▇▇ COPIED Sent: 6/25/2014 3:03:51 PM ET ▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Electronic Record and Signature AdoptionDisclosure: Pre-selected Style Using IP Address: 72.16.81.2 Sent: 3/11/2021 7:19:38 PM Viewed: 3/12/2021 8:25:59 AM Signed: 3/12/2021 8:26:07 AM Accepted: 3/12/2021 8:25:59 AM Not Offered ID: 3bb0d7d6-72a1-44cb-8d50-2a7ce8c383de ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ III COPIED Sent: 6/25/2014 3:03:52 PM ET ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇.▇▇▇ MedImmune Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered ID: ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ COPIED Sent: 6/25/2014 3:03:52 PM ET ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Electronic Record and Signature AdoptionDisclosure: Pre-selected Style Using IP Address: 72.16.81.2 Sent: 3/12/2021 8:26:08 AM Viewed: 3/12/2021 12:38:56 PM Signed: 3/12/2021 12:39:25 PM Accepted: 3/12/2021 12:38:56 PM Not Offered ID: b4e24cf2-4452-41a9-bf30-5f1b3fe60d99 ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇@▇ COPIED Sent: 6/25/2014 3:03:53 PM ET ▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Records Information Manager City of Sugar Land Security Level: Email, Account Authentication (None) Not Offered via DocuSign Eco Dev E-Mail Address ▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Department Account City of Sugar Land Security Level: Email, Account Authentication (None) Not Offered via DocuSign ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered via DocuSign SentID: 3/12/2021 12:39:26 PM Sent: 3/12/2021 12:39:27 PM Sent: 3/12/2021 12:39:27 PM Envelope Sent Hashed/Encrypted 3/9/2021 10:36:44 AM 6/25/2014 3:03:53 PM ET Certified Delivered Security Checked 3/12/2021 12:38:56 6/25/2014 3:03:53 PM ET Signing Complete Security Checked 3/12/2021 12:39:25 6/25/2014 3:03:53 PM ET Completed Security Checked 3/12/2021 12:39:27 6/25/2014 3:03:53 PM Electronic Record and Signature Disclosure created on: 3/20/2017 2:02:24 PM Parties agreed to: ▇▇▇▇ET June 30, 2014 MedImmune, LLC On▇ ▇▇▇▇▇▇▇, Cam ▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇ III From time to time, City of Sugar Land (we, us or Company) may be required by law to provide to you certain written notices or disclosures. Described below are the terms and conditions for providing to you such notices and disclosures electronically through your DocuSign, Inc. (DocuSign) Express user account. Please read the information below carefully and thoroughly, and if you can access this information electronically to your satisfaction and agree to these terms and conditions, please confirm your agreement by clicking the 'I agree' button at the bottom of this document. At any time, you may request from us a paper copy of any record provided or made available electronically to you by us. For such copies, as long as you are an authorized user of the DocuSign system you will have the ability to download and print any documents we send to you through your DocuSign user account for a limited period of time (usually 30 days) after such documents are first sent to you. After such time, if you wish for us to send you paper copies of any such documents from our office to you, you will be charged a $0.00 per-page fee. You may request delivery of such paper copies from us by following the procedure described below. If you decide to receive notices and disclosures from us electronically, you may at any time change your mind and tell us that thereafter you want to receive required notices and disclosures only in paper format. How you must inform us of your decision to receive future notices and disclosure in paper format and withdraw your consent to receive notices and disclosures electronically is described below. If you elect to receive required notices and disclosures only in paper format, it will slow the speed at which we can complete certain steps in transactions with you and delivering services to you because we will need first to send the required notices or disclosures to you in paper format, and then wait until we receive back from you your acknowledgment of your receipt of such paper notices or disclosures. To indicate to us that you are changing your mind, you must withdraw your consent using the DocuSign 'Withdraw Consent' form on the signing page of your DocuSign account. This will indicate to us that you have withdrawn your consent to receive required notices and disclosures electronically from us and you will no longer be able to use your DocuSign Express user account to receive required notices and consents electronically from us or to sign electronically documents from us. Unless you tell us otherwise in accordance with the procedures described herein, we will provide electronically to you through your DocuSign user account all required notices, disclosures, authorizations, acknowledgements, and other documents that are required to be provided or made available to you during the course of our relationship with you. To reduce the chance of you inadvertently not receiving any notice or disclosure, we prefer to provide all of the required notices and disclosures to you by the same method and to the same address that you have given us. Thus, you can receive all the disclosures and notices electronically or in paper format through the paper mail delivery system. If you do not agree with this process, please let us know as described below. Please also see the paragraph immediately above that describes the consequences of your electing not to receive delivery of the notices and disclosures electronically from us. You may contact us to let us know of your changes as to how we may contact you electronically, to request paper copies of certain information from us, and to withdraw your prior consent to receive notices and disclosures electronically as follows: To contact us by email send messages to: ▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇.▇, ▇▇ ▇▇▇▇▇ To let us know of a change in your eAttention: EVP, Research Facsimile: (▇▇▇) ▇▇▇-mail address where we should send notices and disclosures electronically to you▇▇▇▇ MedImmune, you must send an email message to us at LLC On▇ ▇▇▇▇▇▇▇@▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇.▇, ▇▇ and in the body of such request you must state: your previous e-mail address, your new e-mail address. We do not require any other information from you to change your email address.. In addition, you must notify DocuSign, Inc to arrange for your new email address to be reflected in your DocuSign account by following the process for changing e-mail in DocuSign. To request delivery from us of paper copies of the notices and disclosures previously provided by us to you electronically, you must send us an e-mail to ▇▇▇▇▇ Attention: Legal Department Facsimile: (▇▇▇@) ▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ and in the body of such request you must state your e-mail address, full name, US Postal address, and telephone number. We will ▇▇▇▇ you for any fees at Re: License and Option Agreement Ladies and Gentlemen: Reference is made to the License and Option Agreement, effective as of July 24, 2013, by and between MedImmune, LLC and Bulldog Pharmaceuticals, Inc., as amended by that timecertain letter agreement dated February 10, if any2014 and the Addendum to the License and Option Agreement, executed as of June 25, 2014 (collectively, the “Agreement”). To inform us that you no longer want Capitalized terms used but not defined in this letter have the meanings given to receive future notices them in the Agreement. The Parties desire (x) to clarify and disclosures in electronic format you maysupplement certain of their rights and obligations under the Agreement with respect to the Inventory and (y) to clarify their intention regarding the definition of MedImmune Manufacturing Information and Inventions. Accordingly, the Parties agree as follows: